The clinical and laboratory manifestations profile of antiphospholipid syndrome among Saudi Arabia population: Examining the applicability of Sapporo criteria-Reference-Cited by-同舟云学术

The clinical and laboratory manifestations profile of antiphospholipid syndrome among Saudi Arabia population: Examining the applicability of Sapporo criteria

Published:2020-09 Issue:9 Volume:27 Page:2425-2430
ISSN:1319-562X
Container-title:Saudi Journal of Biological Sciences
language:en
Short-container-title:Saudi Journal of Biological Sciences

Author:

Algahtani Farjah H.,AlQahtany Fatmah S.,ElGohary Ghada,Alsharidi Aynaa,Sayeeda Afsar,AlArfaj Hussein,Gamal Ahmed Y.

Funder

Deanship of Scientific Research, King Saud University

Publisher

Elsevier BV

Subject

General Agricultural and Biological Sciences

Reference24 articles.

1. Antiphospholipid syndrome;Khamashta;Best Practice & Res. Clin. Rheumatol.,2016

2. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS);Miyakis;J. Thromb. Haemost.,2006

3. Epidemiology of the antiphospholipid antibody syndrome;Petri;J. Autoimmun.,2000

4. The geoepidemiology of the antiphospholipid antibody syndrome;Biggioggero;Autoimmun. Rev.,2010

5. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome;Wilson;Arthritis Rheum,1999

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of non‐renal manifestations of systemic lupus erythematosus: A systematic literature review for the APLAR consensus statements;International Journal of Rheumatic Diseases;2022-08-02

2. Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: a descriptive cohort study among 1.1 million vaccinated people in Hong Kong;2021-10-23